Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

2.03
Delayed Data
As of Feb 11
 +0.05 / +2.53%
Today’s Change
1.50
Today|||52-Week Range
5.05
-33.88%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a -1.48% decrease from the last price of 2.03.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.13
Sales
$3.6M
Reporting Date
May 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 13.33%
 
 
 
 
 
 
Growthannually 13.73%
 
 
 
 
 
 

Sales

Growthquarterly 428.98%
 
 
 
 
 
 
Growthannually 501.44%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.